EUVIMEDDescubrir EUVIMED
CrossrefTarjeta informativa

Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon Cancer

Dea N.M. Jepsen, Marianne B. Jensen, Trine L. Grantzau, Astrid L.B. Bennedsen, Thomas T. Eriksen, Michael Bzorek, Ismail Gögenur, Anne-Marie K. Fiehn

Applied Immunohistochemistry & Molecular Morphology · 2026-11 · 34 (6) · 403-411

DOI: 10.1097/pai.0000000000001345 ↗
ResumenDatos bibliográficos

Resumen

Programmed death-ligand 1 (PD-L1) is a predictive biomarker in various cancers. In colorectal cancer, PD-L1 expression evaluation is not part of the routine examination and standardized evaluation methods are lacking. This study aimed to examine inter-rater agreement in PD-L1 expression evaluation in patients with colon cancer (CC) using different manual scoring methods, and to compare the manual methods to a digital evaluation. Two pathologists evaluated 188 PD-L1-stained slides from patients with CC. The tumor proportion score (TPS) and immune cell score (ICS) were categorized as

Conocimiento que se adapta a su trabajo.

Desde un inicio gratuito y la búsqueda bibliográfica personal hasta la Research Suite completa.

Ver tarifas →

¿Se incluyen todos los textos completos editoriales?

No. Registros, resúmenes y textos completos son contenidos diferentes. La disponibilidad depende de la fuente, del acceso abierto y de sus licencias. Un plan EUVIMED no sustituye derechos editoriales adicionales.

Ver tarifas →